Haleos Labs Ltd Enters Strategic Development Collaboration with HRV Global Life Sciences

Haleos Labs Ltd has entered into a Strategic Development collaboration with HRV Global Life Sciences Private Limited to accelerate development and GMP manufacturing of orphan drug and niche therapeutic Active Pharmaceutical Ingredients (APIs) for regulated and semi-regulated markets. The collaboration aims to leverage Haleos Labs' USFDA-GMP aligned systems and API manufacturing expertise, while HRV Global will contribute its global market access and regulatory execution capabilities. This collaboration supports Haleos Labs' strategic goal to expand into complex and high value APIs catering to underserved therapeutic segments and strengthens its presence in regulated and semi-regulated markets including US, EU, Latin America, MENA and APAC.